HESHAM MOHAMED to Lymphoma, Large B-Cell, Diffuse
This is a "connection" page, showing publications HESHAM MOHAMED has written about Lymphoma, Large B-Cell, Diffuse.
Connection Strength
0.398
-
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study. Blood. 2025 Apr 03; 145(14):1498-1509.
Score: 0.199
-
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial. Nat Cancer. 2025 Mar; 6(3):528-539.
Score: 0.199